Haisco Pharmaceutical Group

002653 · SZSE · CNY

¥62.18Change from previous close: +0.40%Absolute change: +¥0.25

Close · September 30, 2026

Company profile

Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical products in the areas of anesthesia and analgesic, endocrine system, enteral parenteral nutrition, cardiovascular, psychiatric, tumor-related, digestive liver, and other diseases. Haisco Pharmaceutical Group Co., Ltd. has licensing and research collaboration with Eli Lilly and Company to develop medicines across multiple therapeutic areas. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.

Company facts

Industry
Biotechnology
Country
China
Headquarters
No. 17 Sanxiang Avenue, 856000, Shannan
Employees
5,597
Listing
002653 · SZSE
Currency
CNY
Website
haisco.com